Australia markets closed

Jeil Pharmaceutical Co.,Ltd (271980.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
15,190.000.00 (0.00%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
705,759,254
726,393,758
722,229,924
700,693,229
691,324,837
-
Cost of revenue
537,160,313
542,137,866
565,431,766
544,716,840
534,633,671
-
Gross profit
168,598,941
184,255,893
156,798,159
155,976,389
156,691,166
-
Operating expenses
Research development
-
45,727,389
41,147,440
38,973,748
24,270,197
-
Selling general and administrative
102,053,897
76,481,557
74,632,766
74,724,051
70,258,632
-
Total operating expenses
-
175,367,944
170,130,352
166,356,294
143,786,793
-
Operating income or loss
35,105,322
8,887,949
-13,332,193
-10,379,905
12,904,373
-
Interest expense
-
6,033,022
3,009,253
1,966,932
1,071,496
-
Income before tax
-15,584,963
1,916,093
-13,246,645
-13,833,971
12,551,990
-
Income tax expense
-2,972,312
-3,284,477
1,762,368
1,151,646
5,587,188
-
Income from continuing operations
-12,612,650
5,200,570
-15,009,014
-14,985,618
6,964,802
-
Net income
-10,575,627
5,004,745
-13,090,894
-12,473,279
6,916,121
-
Net income available to common shareholders
-10,575,627
5,004,745
-13,090,894
-12,473,279
6,916,121
-
Basic EPS
250.00
-
-898.00
-854.00
473.00
-698.00
Diluted EPS
250.00
-
-898.00
-854.00
473.00
-698.00
Basic average shares
14,574
-
14,578
14,606
14,614
14,670
Diluted average shares
14,574
-
14,578
14,606
14,614
14,670